- Trials with a EudraCT protocol (156)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
156 result(s) found for: Anomalies.
Displaying page 1 of 8.
EudraCT Number: 2015-001703-32 | Sponsor Protocol Number: VASE | Start Date*: 2015-11-09 | |||||||||||
Sponsor Name:Cliniques Universitaires Saint-Luc (CUSL) | |||||||||||||
Full Title: Phase III multicentric study evaluating the efficacy and safety of sirolimus in Vascular Anomalies that are refractory to standard care | |||||||||||||
Medical condition: Complex vascular anomalies causing debilitating functional and esthetic impairment that are resistant to standard care | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FR (Completed) DE (Ongoing) NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004334-25 | Sponsor Protocol Number: FARM6KWTCT | Start Date*: 2008-08-06 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA | |||||||||||||
Full Title: Efficacy of folic acid at high doses in preventing congenital anomalies. Randomized clinical trial in fertile women who plan a pregnancy: folic acid 4mg vs 0.4mg. | |||||||||||||
Medical condition: Prevention of congenital anomalies in pregnancy. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005199-15 | Sponsor Protocol Number: FSJD-HSJD-1 | Start Date*: 2008-02-27 | |||||||||||
Sponsor Name:HOSPITAL SANT JOAN DE DÉU | |||||||||||||
Full Title: TRATAMIENTO DE LOS TUMORES VASCULARES DEL DESARROLLO CON BEVACIZUMAB A PHASE II STUDY OF BEVACIZUMAB FOR VASCULAR TUMORS OF CHILDHOOD | |||||||||||||
Medical condition: VASCULAR ANOMALIES | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002157-38 | Sponsor Protocol Number: 57911 | Start Date*: 2017-09-14 | ||||||||||||||||||||||||||
Sponsor Name:Radboud University Medical Center | ||||||||||||||||||||||||||||
Full Title: Treatment of congenital vascular malformations using Sirolimus: improving quality of Life | ||||||||||||||||||||||||||||
Medical condition: congenital vascular malformation : Vascular malformations can involve lymphatic vessels, capillaries, veins and arteries or even combinations. These vascular malformations are present at birth an... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-001082-15 | Sponsor Protocol Number: IPC2006-07 | Start Date*: 2008-07-31 | |||||||||||
Sponsor Name:Institut Paoli Calmette | |||||||||||||
Full Title: Etude de Phase I-II multicentrique de l'association Cloretazine-Daunorubicine-Aracytine dans le traitement des leucémies aigües myéloïdes du groupe cytogénétique défavorable. | |||||||||||||
Medical condition: Malades atteints de Leucémie Aigüe Myéloïde | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019713-21 | Sponsor Protocol Number: CS/2007/2678 | Start Date*: 2010-06-17 | ||||||||||||||||||||||||||
Sponsor Name:University Hospitals Bristol NHS Foundation Trust | ||||||||||||||||||||||||||||
Full Title: A RANDOMISED CONTROLLED TRIAL TO COMPARE NORMOXIC VERSUS STANDARD CARDIOPULMONARY BYPASS IN CYANOTIC CHILDREN UNDERGOING CARDIAC SURGERY | ||||||||||||||||||||||||||||
Medical condition: The study investigates reoxygenation injury in cyanotic paediatric patients undergoing on-pump cardiac surgery. The types of heart condition being investigated result in chronic low blood oxygen sa... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-003325-10 | Sponsor Protocol Number: 1.01 | Start Date*: 2012-08-10 | |||||||||||||||||||||
Sponsor Name:VU University Medical Center | |||||||||||||||||||||||
Full Title: A randomized controlled trail on the effects of periconceptional and prenatal folic acid supplementation on congenital anomalies and preterm birth | |||||||||||||||||||||||
Medical condition: congenital anomalies | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: NL (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004322-28 | Sponsor Protocol Number: P120910 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000517-33 | Sponsor Protocol Number: RP-L201-0318 | Start Date*: 2020-07-14 | |||||||||||
Sponsor Name:Rocket Pharmaceuticals, Inc. | |||||||||||||
Full Title: Gene Therapy for Leukocyte Adhesion Deficiency-I (LAD-I):A Phase I/II Clinical Trial to Evaluate the Safety and Efficacy of the Infusion of Autologous Hematopoietic Stem Cells Transduced with a Len... | |||||||||||||
Medical condition: Leukocyte Adhesion Deficiency-I (LAD-I) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002680-26 | Sponsor Protocol Number: RP-L201-0218 | Start Date*: 2018-11-27 | |||||||||||
Sponsor Name:Rocket Pharmaceuticals, Inc. | |||||||||||||
Full Title: Gene Therapy for Leukocyte Adhesion Deficiency-I (LAD-I): A Phase I Clinical Trial to Evaluate the Safety and Efficacy of the Infusion of Autologous Hematopoietic Stem Cells Transduced with a Lenti... | |||||||||||||
Medical condition: Leukocyte Adhesion Deficiency-I (LAD-I) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-009956-20 | Sponsor Protocol Number: ICG-REG_01 | Start Date*: 2009-05-29 | |||||||||||
Sponsor Name:Free State of Bavaria rep. by the Univ. of Regensburg, rep. by the Regensburg Univ. Hospital | |||||||||||||
Full Title: Prospective, randomized, controlled, mono-centric, two-armed, single-blinded pilot study for the treatment of venous and capillary vascular malformations by Indocyanine Green-augmented laser therapy | |||||||||||||
Medical condition: venous and capillary vascular malformations | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004723-36 | Sponsor Protocol Number: 29BRC18.0275 | Start Date*: 2019-09-18 | |||||||||||
Sponsor Name:CHRU de Brest | |||||||||||||
Full Title: TEP/TDM pulmonaire de ventilation-perfusion au Gallium68 pour le diagnostic de l'embolie pulmonaire : une étude diagnostique versus angioscanner thoracique. | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002057-38 | Sponsor Protocol Number: 64091742PCR2001 | Start Date*: 2016-09-26 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: A Phase 2 Efficacy and Safety Study of Niraparib in Men with Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies | |||||||||||||
Medical condition: mCRPC and DNA-repair anomalies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: SE (Completed) GB (GB - no longer in EU/EEA) ES (Ongoing) BE (Completed) DK (Prematurely Ended) NL (Completed) FR (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005748-10 | Sponsor Protocol Number: 2004/077/HP | Start Date*: 2007-04-24 |
Sponsor Name:CHU - Hôpitaux de Rouen | ||
Full Title: Traitement des syndromes d'hypersensibilité médicamenteuse par Immunoglobuline polyvalente IV (Tégéline ) | ||
Medical condition: Syndrome d'Hypersensibilité médicamenteuse : DRESS (Drug Reaction with Eosinophilia and Systemic Symptom) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002710-23 | Sponsor Protocol Number: P140203 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004981-16 | Sponsor Protocol Number: 1991-201-008 | Start Date*: 2022-06-17 | |||||||||||
Sponsor Name:Editas Medicine, Inc. | |||||||||||||
Full Title: Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Efficacy of EDIT-101 in Adult and Pediatric Participants with Leber Congenital Amaurosis Type 10 (LCA10), with Cen... | |||||||||||||
Medical condition: Leber Congenital Amaurosis Type 10 (LCA10), with Centrosomal Protein 290 (CEP290)-Related Retinal Degeneration Caused by a Compound Heterozygous or Homozygous Mutation Involving c.2991+1655A>G in I... | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001096-43 | Sponsor Protocol Number: PHRN14-AM/PERFORMUS | Start Date*: 2015-07-10 | |||||||||||
Sponsor Name:CHRU de Tours | |||||||||||||
Full Title: Treatment of superficial voluminous complicated slow-flow vascular malformations with sirolimus: a phase 2 trial in children observational-phase designed | |||||||||||||
Medical condition: vascular malformations | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000791-26 | Sponsor Protocol Number: PHRI13-GF/LEVNEONAT-1 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:CHRU TOURS | |||||||||||||
Full Title: Lévétiracétam pour le traitement en première intention des convulsions du nouveau-né : étude de phase II | |||||||||||||
Medical condition: Nouveau-nés à terme présentant des convulsions dans les premières 72h de vie. Nés dans un contexte d'asphyxie périnatale qu'ils soient éligibles ou non à l'hypothermie thérapeutique. | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005525-29 | Sponsor Protocol Number: P070115 | Start Date*: 2009-07-31 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Traitement in utero de l’infection congénitale à cytomegalovirus (CMV) par valaciclovir : essai prospectif randomisé contre placebo | |||||||||||||
Medical condition: L'infection par cytomégalovirus chez la femme enceinte. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002436-82 | Sponsor Protocol Number: EC11-441 | Start Date*: 2012-12-13 |
Sponsor Name:Isabel Pinilla Lozano | ||
Full Title: Melatonin effects on visual and sleep patterns anomalies in subjects diagnosed with Retinitis Pigmentosa | ||
Medical condition: To evaluate the sleep quality in patients with Retinitis Pigmentosa | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
